Tei Pharmaceutical (002728.SZ) released its performance for the first three quarters, with net profit attributable to shareholders of RMB 49.4497 million, down 24.18% year on year.

Zhitong Finance APP News, Teyi Pharmaceutical (002728.SZ) released its 2026 third-quarter report. In the first three quarters, the company achieved operating revenue of 624 million yuan, a year-on-year decrease of 9.87%; net profit attributable to shareholders of the listed company was 49.4497 million yuan, a year-on-year decrease of 24.18%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 47.2418 million yuan, a year-on-year decrease of 24.79%; basic earnings per share were 0.1 yuan.